Pinnacle Life Science Pvt. Ltd: A Legacy of Excellence in Healthcare

Established in 2015, Pinnacle Life Science Pvt. Ltd is a proud subsidiary of Aarti Drugs Ltd (ADL) and is an integral part of the esteemed Aarti Group of Industries, a $ 1.5 billion conglomerate. With a rich legacy of 35 years in healthcare through Aarti Drugs Ltd, we have expanded our horizons in every direction, specializing in bulk APIs, intermediates, and finished formulations.

At Pinnacle, we take pride in our extensive portfolio, which encompasses medications for both acute and chronic ailments. Our production prowess is evident with an annual capacity of producing 3 billion tablets and 300 million capsules.

Over the years, we have built a powerful team of highly qualified scientists, technicians and accredited facilities that has contributed in providing the best of products to the global healthcare industry.

With operations spread across various states in India, partnering with 40+ clients and exporting to over 90+ countries, we truly believe that Research and Development combined with a strong sense of customer centric service has been the backbone of our scalable success. Starting from a humble beginning, Pinnacle has truly evolved to become the torch bearer of Aarti Drugs.

  • We invest in scientific and technical excellence through our R&D centre in Turbhe, Navi Mumbai to develop and launch a plethora of new products that meets the needs of patients and patrons.
  • Pinnacle has its own subsidiary in Chile for supplying our products in the LATAM region.
  • We have our offshore offices in Dubai and UK to manage overseas operations.
  • We have amalgamated with Canadian and UK’s finest associates to expand our footprints in the global market.

Pinnacle Lifescience is boosting its promotional launch of a basket of products to cater to the healthcare needs of African region.

Global Footprint

Our global presence spans across North America, Central America, Latin America (including Brazil and Mexico), Europe, UK, the MENA region, French West Africa, East Africa, Australia, Central Asia, and Southeast Asia.

We are proud to announce our partnership with 250+ esteemed clients, reflecting our commitment to excellence and collaboration. Our global footprint is evident with our presence in 90+ countries. As part of our growth strategy, we are actively seeking partnerships to expand our operations in regions including Australia, Central America, China, North America, Canada, Brazil, EU, New Zealand, South Africa, and Latin America

State-of-the-Art Manufacturing

Pinnacle boasts two cutting-edge cGMP-compliant manufacturing facilities in India, catering to a wide range of therapeutic categories such as Anti-Diabetic, Anti-Cancer, Anti-Bacterials, Anti-Protozoal, Anti-Fungal, Anti-Allergic, Anti-Hypertensive, Anthelmintics, Gastrointestinal, and Analgesics.

At Pinnacle, we believe in collaborative growth. We are open to various business models, including Licensing & Supplies, Co-Development, Contract Development, Contract Manufacturing, and Tech Transfer with API supplies.

Pioneering Community Wellbeing

Our Social Values

Developing Healthcare Innovations that adhere to Social
Responsibilities, Quality, Compliance and unassailable Ethics.

Meeting Health and Safety Standards

Our Organisational Guidelines ensures the Safe Development of quality generic and innovative products, that are Cost Sensitive.

Our Core Values

We are a Globally Acclaimed Pharmaceutical Organisation, built on a strong foundation of Integrity, Good Ethics and Commitment.

Sustainability is a part of our Evolutions

We’ve adopted Sustainable Strategies to achieve advancements in the drug delivering, to improve health outcomes.

Drug Delivery Advancements

We’ve achieved Unparalleled Excellence in Innovation of the Biomedical Science through Research and Development.

Innovation Centres

Our goal is to Investigate New Age Drug Accelerators, by adopting a Cross Functional approach

Promoting a Transparent Work Environment

Our organisation’s policies encourages Diversity, provides Equal Work Opportunities and maintains Dignity at all levels

Pioneering Community Wellbeing

Our Social Values

Developing Healthcare Innovations that adhere to Social
Responsibilities, Quality, Compliance and unassailable Ethics.

Meeting Health and Safety Standards

Our Organisational Guidelines ensures the Safe Development of quality generic and innovative products, that are Cost Sensitive.

Our Core Values

We are a Globally Acclaimed Pharmaceutical Organisation, built on a strong foundation of Integrity, Good Ethics and Commitment.

Sustainability is a part of our Evolutions

We’ve adopted Sustainable Strategies to achieve advancements in the drug delivering, to improve health outcomes.

Drug Delivery Advancements

We’ve achieved Unparalleled Excellence in Innovation of the Biomedical Science through Research and Development.

Innovation Centres

Our goal is to Investigate New Age Drug Accelerators, by adopting a Cross Functional approach

Promoting a Transparent Work Environment

Our organisation’s policies encourages Diversity, provides Equal Work Opportunities and maintains Dignity at all levels

OUR TEAM

Meet our visionary leaders, who formulate and execute our core strategies and also bring innovative products to life. We, at Pinnacle strive to bring the best healthcare products to you.

vishwa-new-2020

Vishwa Savla

Founder, Managing Director and CEO

It is our pleasure to introduce Pinnacle Life Sciences visioned and founded by our MD & CEO Mr. Vishwa Savla, MBA from Indian School of Business (I.S.B.) and graduation from Aston University (U.K).Pinnacle Life Sciences is the result of meticulous planning, research & development and marketing over the last 5 years.

While Pinnacle is a young and extremely fast growing organisation, we are strongly backed by our parent organization Aarti Drugs Limited, which has more than 3 decades of strong presence in the API industry and a global presence in over a 100 countries.

To best serve our clients we believe in establishing a range of international strategic partnership to strengthen all activities from development to commercialization, product supply and marketing. We work continuously to consolidate a position as leading generic pharmaceutical company, worldwide and as your trusted healthcare partner providing you best in class products available.

Our knowledge, abilities, capability to innovate, productivity, an extremely strong backward integration of API’s, young, dynamic and talented leadership and team, R&D driven and focused marketing strategies enable us to respond to your and your family needs.

We have proven ourselves in last 5 years as a successful and growing organization and would continue to grow in future with our current product range and by introducing new, innovative products  to our markets, supported by a harmonized production and distribution capability. We aim to become one of the Top 10 Pharmaceutical companies in India with a global presence and complete integration.

We welcome you to connect with us for any enquiries or to share your thoughts and suggestions to add value to our products.

Leadership

Juan Gomez

LATAM head, Director of Pinnacle Chile SpA

A specialist in negotiation processes with foreign suppliers, as well as in the coordination of the sanitary registry process, commercial and marketing strategies, with deep knowledge of the Chilean and international pharmaceutical market.

With more than 30 years of experience in in national and multinational pharmaceutical companies like Bayer, Andromaco-Grünenthal and Eurofarma, Juan is the Founder of Four Pharma, a company that provides pharmaceutical field solutions in the search for suppliers of finished products and raw materials.

Richie Gandhi

-VP: International Business Development and Strategic Alliance

With a Masters Degree in Chemical Engineering from Aston University, Richie Gandhi leads our organisation as the Vice President of International Business Development and Strategic Alliance.

Having over 10 years of experience working in some of the most highly renowned pharmaceutical organisations like Sanofi, Dr. Reddy’s etc. Richie has extensive experience in corporate strategy, project management in international markets and plays a vital role at Pinnacle Life Science.

Dr. Vinay Nayak

-Independent director of Aarti Industries Ltd

Dr. Nayak is a highly distinguished pharmaceutical professional having acquired a PhD in Analytical Chemistry from Ruia college, under the Guidance of Dr RT Sane and has over 35 years of work experience in organisations such as Cipla, Lupin, Watson, Alembic & Emcure.

Specialised in the fields of Manufacturing, Quality, R&D, Compliance and Regulatory Affairs, Dr. Nayak leads our team as an Independent Director at Aarti Industries.

Board of Directors

Harshit

Shri Harshit M. Savla

Non-executive Director

Shri Harshit M. Savla is the Non-executive Director of the Company. He is associated with the Company since 2014. He is a Commerce Graduate having more than 35 years of experience in Finance, Export and Administration. He also serves as the Joint Managing Director of the Holding Company, Aarti Drugs Limited. He played a crucial role in expanding the Formulation business of the Company.

Pinnacle

Shri Navin C. Shah

Independent Director

Shri Navin C. Shah has been appointed as an Independent Director of the Company since April 2022. He also serves as Independent Director of the Holding Company, Aarti Drugs Limited. He holds a Bachelor’s Degree in Commerce and is a Chartered Accountant. He is a practicing Chartered Accountant with more than 37 years of experience in the field of Income Tax related matters. He has expertise in Goods and Service Tax (GST).

Harit

Shri Harit P. Shah

Non-executive Director

Shri Harit P. Shah is the Non-executive Director of the Company. He is associated with the Company since 2014. He is a Commerce Graduate and has experience of more than 35 years in the handling commercial functions encompassing Sales, Purchases and Exports. He also serves as the Executive Director of the Holding Company, Aarti Drugs Limited and looks after local sales and exports as well. He has in-depth knowledge of the Pharmaceutical industry.

Adhish

Shri Adhish P. Patil

Non-executive Director

Shri Adhish P. Patil is the Non-executive Director of the Company. He is associated with the Company since 2014. He is a proven leader with eighteen years of experience in Manufacturing Operations, Finance, Investor Relations, Regulatory Compliance, Consulting, Systems Engineering and Information Technology for the Pharmaceutical and Consulting industries. He has a Bachelor of Engineering (IT) degree from Mumbai University. He is a gold medalist from the University of Florida’s Warrington College of Business Administration with an MBA in Finance and Marketing. He was named to the coveted ‘Top 100 CFOs India 2014’ list. He has managed production efficiencies, projects, financial operations, ERP implementation, automations for regulatory compliances for a publicly traded pharmaceutical Company. He also serves as Chief Financial Officer at Holding Company, Aarti Drugs Limited.

Our Group Companies

Pinncale-Sub-Add-Logo

Pinnacle Life Science is a wholly owned subsidiary of Aarti Drugs Ltd, and also a part of the esteemed Aarti Group of Industries. Our parent organisations have paved the path for pathbreaking innovations and have achieved success in their respective fields.

aarti-drug-logo

Aarti Drugs Ltd. was established in the year 1984, forms a part of Aarti Group of Industries and it has carved a niche for itself in the pharmaceutical industry. The company is engaged in the manufacturing of Active Pharmaceutical Ingredients (API’s), Pharma Intermediates, Specialty Chemicals and Formulations.

aarti-industry-logo

Aarti Industries is an emerging global partner to leading consumers of speciality chemicals and intermediates. Chemicals manufactured by them are used in the production of pharmaceuticals, agrochemicals, polymers, additives, surfactants, pigments, dyes etc.

Corporate Social Responsibility

It is important to look at the growth of a Company from a multisectoral lens. This approach is not just what affects us or our immediate set of people or things, but all the people, all the tangible and intangible resources that are affected by our actions. At Aarti Group, we believe that we can only grow if everyone grows with us. For this, we have taken initiatives to work towards creating a culture of inclusivity in the Company and helping the communities uplift themselves.

Pinnacle Lifescience is strongly committed to achieving excellence on environmental, health and safety grounds. Our organisation continues to invest substantial resources towards sustaining and improving the standards of environment, occupational health and safety as we believe in contributing towards the betterment of our society.

We actively contribute to :

1) Education and Skill Development

2) Health

3) Environment

4) Social Welfare

5) Rural Development

6) Women Empowerment

7) Running a Quarterly Medical Camp across a few
rural areas in India

We have been working on these projects through Aarti Foundation and various other NGO’s.

The success of Pinnacle Life Science, lies in the deep rooted values of our founding fathers. Our ambitious goal is to become a pioneer in developing record breaking scientific advancements, while also fulfilling our social responsibilities towards our society. The driving force of our success, is being able to serve our customers and our communities better. Let’s take a look at our journey.

Born to be Leaders

Inception of our flagship organisation, Aarti Drugs

Stepping Stone to our Success

This was the turning point for our organisation as we achieved a turnover of USD 15 million

Global Recognition

Aarti Drugs got approved by the US FDA

Our Prosperity

After nearly 3 decades of healthcare service, we achieved a turnover of USD 150 million

The birth of Pinnacle Life Science

Inception and Incorporation of Pinnacle Life Science Pvt Ltd a formulation arm and a 100% subsidiary Aarti Drugs Ltd

Our Growing Family

Operations commenced at the Pinnacle Life Science (Sikkim) plant. This was a monumental year for PLS, as we also achieved a turnover of USD 15 million

Global Expansion

Pinnacle Life Science witness rapid growth and expansion, hence we founded the Pinnacle Chile and Formulation R&D Centre

Future Milestones

Our Formulation department is currently exporting to over 40 + countries and we’re looking to expand further more in the coming years. By 2021, we will officially expand to LATAM and Africa and our plants will also be approved PIC/S

As a part of our expansion strategy, our Formulation department will also start exporting to countries like EU, LATAM, Canada and Australia. Our new and upcoming plants will be approved by PIC/S and Europe. On the basis of our current market growth, we aim to achieve a revenue of USD 62 million

Pinnacle Life Science will emerge to become the fore runner in bulk manufacturing of cost effective pharmaceutical formulations. By the year 2025, we intend to achieve a revenue of USD 105 million

The success of Pinnacle Life Science, lies in the deep rooted values of our founding fathers. Our ambitious goal is to become a pioneer in developing record breaking scientific advancements, while also fulfilling our social responsibilities towards our society. The driving force of our success, is being able to serve our customers and our communities better. Let’s take a look at our journey.

Born to be Leaders

Inception of our flagship organisation, Aarti Drugs

Stepping Stone to our Success

This was the turning point for our organisation as we achieved a turnover of USD 15 million

Global Recognition

Aarti Drugs got approved by the US FDA

Our Prosperity

After nearly 3 decades of healthcare service, we achieved a turnover of USD 150 million

The birth of Pinnacle Life Science

Inception and Incorporation of Pinnacle Life Science Pvt Ltd a formulation arm and a 100% subsidiary Aarti Drugs Ltd

Our Growing Family

Operations commenced at the Pinnacle Life Science (Sikkim) plant. This was a monumental year for PLS, as we also achieved a turnover of USD 15 million

Global Expansion

Pinnacle Life Science witness rapid growth and expansion, hence we founded the Pinnacle Chile and Formulation R&D Centre

Future Milestones

Our Formulation department is currently exporting to over 40 + countries and we’re looking to expand further more in the coming years. By 2021, we will officially expand to LATAM and Africa and our plants will also be approved PIC/S

As a part of our expansion strategy, our Formulation department will also start exporting to countries like EU, LATAM, Canada and Australia. Our new and upcoming plants will be approved by PIC/S and Europe. On the basis of our current market growth, we aim to achieve a revenue of USD 62 million

Pinnacle Life Science will emerge to become the fore runner in bulk manufacturing of cost effective pharmaceutical formulations. By the year 2025, we intend to achieve a revenue of USD 105 million